VOYA INVESTMENT MANAGEMENT LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$925,641
-19.5%
20,127
+0.7%
0.00%0.0%
Q2 2023$1,149,228
+55.6%
19,997
+1.5%
0.00%0.0%
Q1 2023$738,600
+33.8%
19,6960.0%0.00%0.0%
Q4 2022$551,882
-0.3%
19,6960.0%0.00%0.0%
Q3 2022$553,458
-19.2%
19,6960.0%0.00%
-50.0%
Q2 2022$685,000
-8.7%
19,696
-5.7%
0.00%0.0%
Q1 2022$750,000
-6.2%
20,891
-39.2%
0.00%0.0%
Q4 2021$800,000
+28.6%
34,370
+5.1%
0.00%
+100.0%
Q3 2021$622,000
+19.2%
32,717
+26.3%
0.00%0.0%
Q2 2021$522,000
+47.0%
25,907
+33.6%
0.00%0.0%
Q1 2021$355,000
+7.9%
19,392
+18.7%
0.00%0.0%
Q4 2020$329,000
+36.5%
16,341
+27.1%
0.00%0.0%
Q3 2020$241,000
-97.5%
12,853
-97.0%
0.00%
-95.5%
Q2 2020$9,635,000
+22.8%
428,966
-18.9%
0.02%
+4.8%
Q1 2020$7,845,000
-27.4%
528,701
-5.6%
0.02%
-4.5%
Q4 2019$10,808,000
-9.7%
560,254
-7.1%
0.02%
-15.4%
Q3 2019$11,965,000
+3503.9%
603,377
+3731.0%
0.03%
+2500.0%
Q2 2019$332,000
+4.7%
15,750
+1.6%
0.00%0.0%
Q1 2019$317,000
-1.6%
15,505
-4.1%
0.00%0.0%
Q4 2018$322,000
-58.1%
16,160
-59.5%
0.00%
-50.0%
Q3 2018$768,000
+25.9%
39,9420.0%0.00%
+100.0%
Q2 2018$610,000
-46.7%
39,942
-34.6%
0.00%
-50.0%
Q1 2018$1,145,000
-2.6%
61,0840.0%0.00%0.0%
Q4 2017$1,175,000
+7.6%
61,0840.0%0.00%0.0%
Q3 2017$1,092,000
+0.1%
61,0840.0%0.00%0.0%
Q2 2017$1,091,000
+9.2%
61,084
-11.3%
0.00%0.0%
Q1 2017$999,000
+12.6%
68,864
+43.0%
0.00%0.0%
Q4 2016$887,000
+223.7%
48,160
+233.5%
0.00%
+100.0%
Q3 2016$274,000
+17.6%
14,4400.0%0.00%0.0%
Q2 2016$233,000
+34.7%
14,4400.0%0.00%
Q1 2016$173,000
-15.6%
14,4400.0%0.00%
-100.0%
Q4 2015$205,000
+21.3%
14,4400.0%0.00%
Q3 2015$169,000
-33.5%
14,4400.0%0.00%
-100.0%
Q2 2015$254,00014,4400.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders